<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR51">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fang</surname>
    <given-names>EF</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>CZY</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>TB</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>JH</given-names>
   </name>
   <name>
    <surname>Pan</surname>
    <given-names>WL</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>XJ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and 
   <italic>in vivo</italic>
  </article-title>
  <source>Cancer Prev Res (Phila)</source>
  <year>2012</year>
  <volume>5</volume>
  <fpage>109</fpage>
  <lpage>121</lpage>
  <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-11-0203</pub-id>
  <pub-id pub-id-type="pmid">21933914</pub-id>
 </element-citation>
</ref>
